tiprankstipranks
Trending News
More News >
Neuphoria Therapeutics (NEUP)
NASDAQ:NEUP
US Market

Neuphoria Therapeutics (NEUP) Income Statement

Compare
300 Followers

Neuphoria Therapeutics Income Statement

Last quarter (Q2 2026), Neuphoria Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Neuphoria Therapeutics's net income was AU$1.86M. See Neuphoria Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 23.95MAU$ 0.00AU$ 0.00-AU$ 0.00
Gross Profit
AU$ 22.94MAU$ -992.56KAU$ -671.42KAU$ 0.00AU$ -1.69M
Operating Expenses
AU$ 24.67MAU$ 25.79MAU$ 21.58MAU$ 27.71MAU$ 11.26M
Depreciation and Amortization
AU$ 1.01MAU$ 992.56KAU$ 671.42KAU$ 1.17MAU$ 1.69M
EBITDA
AU$ -268.02KAU$ -22.33MAU$ -21.54MAU$ -28.03MAU$ -6.63M
Operating Income
AU$ -1.73MAU$ -26.79MAU$ -22.26MAU$ -28.60MAU$ -12.95M
Other Income/Expenses
AU$ 445.56KAU$ 3.46MAU$ 39.87K--
Pretax Income
AU$ -1.28MAU$ -23.32MAU$ -22.22MAU$ -29.24MAU$ -9.76M
Net Income
AU$ -565.77KAU$ -23.19MAU$ -21.65MAU$ -22.94MAU$ -8.65M
Per Share Metrics
Basic EPS
AU$ -0.23AU$ -0.10AU$ -0.17AU$ -0.13AU$ -0.10
Diluted EPS
AU$ -0.23AU$ -0.10AU$ -0.17AU$ -0.13AU$ -0.10
Weighted Average Shares Outstanding
1.62M 149.80M 122.39M 112.78M 65.00M
Weighted Average Shares Outstanding (Diluted)
1.62M 149.80M 122.39M 112.78M 65.00M
Currency in AUD

Neuphoria Therapeutics Earnings and Revenue History